Associated Papers
Prediction tools for assessing functional impacts of gene mutations in Clear Cell Renal Cell Carcinoma: A comparative study.
Yang CH et al.
Computers in Biology and Medicine, 2025
Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma.
Schoenfeld DA et al.
Molecular Cancer Research : Mcr, 2022
High affinity binding of H3K14ac through collaboration of bromodomains 2, 4 and 5 is critical for the molecular and tumor suppressor functions of PBRM1.
Liao L et al.
Molecular Oncology, 2019
BAF180: Its Roles in DNA Repair and Consequences in Cancer.
Hopson S et al.
Acs Chemical Biology, 2017
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma.
Piva F et al.
Oncotarget, 2015
26452128 (PubMed )
Supplement: oncotarget-06-32161-s002.xls › Predictions
BAF180 promotes cohesion and prevents genome instability and aneuploidy.
Brownlee PM et al.
Cell Reports, 2014
BAP1 loss defines a new class of renal cell carcinoma.
Peña-Llopis S et al.
Nature Genetics, 2012
22683710 (PubMed )
Supplement: NIHMS377160-supplement-Suppl__Data_3.xlsx › Suppl._Data_3
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.
Varela I et al.
Nature, 2011
Select a paper to view details